v3.26.1
SCHEDULE OF IN-PROCESS RESEARCH AND DEVELOPMENT ACTIVITY (Details)
 12 Months Ended
Mar. 31, 2026
USD ($)
Restructuring Cost and Reserve [Line Items]  
Balance as of March 31, 2025 $ 42,708,079
Foreign currency translation adjustment 2,798,392
Balance as of March 31, 2026 45,506,471
Orocidin A/S [Member]  
Restructuring Cost and Reserve [Line Items]  
Balance as of March 31, 2025 15,679,626
Foreign currency translation adjustment 1,027,387
Balance as of March 31, 2026 16,707,013
Bio-Convert A/S [Member]  
Restructuring Cost and Reserve [Line Items]  
Balance as of March 31, 2025 27,028,453
Foreign currency translation adjustment 1,771,005
Balance as of March 31, 2026 $ 28,799,458